Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy R Shultz

Showing results (31-40 of 181) with videos related to

Pageof 19
Sort By:
Neurobiology of Stress|November 20, 2018
Elimination of vesicular zinc alters the behavioural and neuroanatomical effects of social defeat stress in miceBrendan B McAllister, David K Wright, Ryan C Wortman, et al.
Journal of Neurotrauma|April 20, 2026
The Neurological Impact of Repetitive Low-Level Blast Overpressure ExposureAntony Sutherland, Stuart J McDonald, Gershon Spitz, et al.
Journal of Neurotrauma|June 14, 2014
The acute phase of mild traumatic brain injury is characterized by a distance-dependent neuronal hypoactivityVictoria P A Johnstone, Sandy R Shultz, Edwin B Yan, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 16, 2025
Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injuryZoe Plummer, Josh Allen, Justin Brand, et al.
Brain Sciences|May 2, 2020
Examining the Effects of Anabolic-Androgenic Steroids on Repetitive Mild Traumatic Brain Injury (RmTBI) Outcomes in Adolescent RatsJason Tabor, David K Wright, Jennaya Christensen, et al.
Neuropharmacology|May 11, 2016
Sodium selenate, a protein phosphatase 2A activator, mitigates hyperphosphorylated tau and improves repeated mild traumatic brain injury outcomesXin L Tan, David K Wright, Shijie Liu, et al.
Molecular Neurobiology|December 11, 2013
Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbiditiesPing Zheng, Sandy R Shultz, Chris M Hovens, et al.
Journal of Neuroinflammation|April 8, 2020
The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic targetWilliam T O'Brien, Louise Pham, Georgia F Symons, et al.
Journal of Neuroinflammation|January 15, 2017
Inflammation in epileptogenesis after traumatic brain injuryKyria M Webster, Mujun Sun, Peter Crack, et al.
Brain Communications|September 21, 2020
Investigating the cumulative effects of Δ9-tetrahydrocannabinol and repetitive mild traumatic brain injury on adolescent ratsDhyey Bhatt, Ali Hazari, Glenn R Yamakawa, et al.
Pageof 19

Showing results (31-40 of 181) with videos related to

Sort By:
Pageof 19
Neurobiology of Stress|November 20, 2018
Elimination of vesicular zinc alters the behavioural and neuroanatomical effects of social defeat stress in miceBrendan B McAllister, David K Wright, Ryan C Wortman, et al.
Journal of Neurotrauma|April 20, 2026
The Neurological Impact of Repetitive Low-Level Blast Overpressure ExposureAntony Sutherland, Stuart J McDonald, Gershon Spitz, et al.
Journal of Neurotrauma|June 14, 2014
The acute phase of mild traumatic brain injury is characterized by a distance-dependent neuronal hypoactivityVictoria P A Johnstone, Sandy R Shultz, Edwin B Yan, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 16, 2025
Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injuryZoe Plummer, Josh Allen, Justin Brand, et al.
Brain Sciences|May 2, 2020
Examining the Effects of Anabolic-Androgenic Steroids on Repetitive Mild Traumatic Brain Injury (RmTBI) Outcomes in Adolescent RatsJason Tabor, David K Wright, Jennaya Christensen, et al.
Neuropharmacology|May 11, 2016
Sodium selenate, a protein phosphatase 2A activator, mitigates hyperphosphorylated tau and improves repeated mild traumatic brain injury outcomesXin L Tan, David K Wright, Shijie Liu, et al.
Molecular Neurobiology|December 11, 2013
Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbiditiesPing Zheng, Sandy R Shultz, Chris M Hovens, et al.
Journal of Neuroinflammation|April 8, 2020
The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic targetWilliam T O'Brien, Louise Pham, Georgia F Symons, et al.
Journal of Neuroinflammation|January 15, 2017
Inflammation in epileptogenesis after traumatic brain injuryKyria M Webster, Mujun Sun, Peter Crack, et al.
Brain Communications|September 21, 2020
Investigating the cumulative effects of Δ9-tetrahydrocannabinol and repetitive mild traumatic brain injury on adolescent ratsDhyey Bhatt, Ali Hazari, Glenn R Yamakawa, et al.
Pageof 19